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Introduction
Mutations in TNFRSF1A can result in the autosomal
dominant TNF receptor-associated periodic syndrome
(TRAPS): a complex and heterogeneous systemic auto-
inflammatory disorder. Misfolding, intracellular aggrega-
tion and ligand-independent signalling by mutant TNFR1
play central roles in disease pathophysiology.
Objectives
This work was conducted to study the intracellular signal-
ling pathway activation elicited by mutant TNFR1.
Methods
To understand the complexity of intracellular signalling
pathway perturbation in TRAPS, a prototypic mutant
TNFR1 (C33Y), or wild-type TNFR1 (WT), were expressed
at near physiological levels in an SK-Hep-1 cell model
system. TNFR1-associated signalling pathway intermedi-
ates were examined under a range of conditions, employ-
ing reverse-phase protein microarray. Peripheral blood
mononuclear cells (PBMC) from C33Y TRAPS patients
and matched healthy controls were similarly examined.
Results
In comparison to cells expressing WT TNFR1 alone,
expression of C33Y-TNFR1 in SK-Hep–1 cells and
TRAPS patients’ PBMCs revealed a subtle up-regulation
of a wide spectrum of signalling intermediates and their
phosphorylated forms. These were associated with a proin-
flammatory/ anti-apoptotic phenotype, including NF-k B,
p38, MEK/ERK and JNK MAP kinase pathways, Phosphoi-
nositide 3 kinase, STAT3, JAK2/c-Src, Gsk-3b and tran-
scription factors (including ATF, Elk, Jun). Increased
activated Jak2/STAT3 may contribute to an “IL6
amplifier” positive feedback loop that promotes and
sustains a proinflammatory state.
Conclusion
The study thus reveals the pleiotropic effect of a TRAPS-
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